[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577885":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":38,"locations":43,"responsibleParty":56,"collaborators":25,"id":58,"slug":25,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":25,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":45,"whyStopped":25,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Temple University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active Stimulation","EXPERIMENTAL","Participants in the active arm will receive a 2-min transcutaneous vagus nerve stimulation using a portable hand-held digital wellness Truvaga Plus device by placing it on the anterolateral cervical area of the neck.",[13],"Device: Active nVNS",{"label":15,"type":10,"description":16,"interventionNames":17},"Control Stimulation","Participants in the control arm will receive a 2-min transcutaneous stimulation using a portable hand-held digital wellness Truvaga Plus device by placing it on the posterolateral part of the neck (near the overlapping area between the trapezeus muscle and the shoulder).",[18],"Device: Control nVNS",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Active nVNS","2-min transcutaneous nVNS stimulation using portable Truvaga Plus Device (electroCore Inc., Rockaway, NJ).",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Control nVNS","2-min control stimulation using portable Truvaga Plus Device (electroCore Inc., Rockaway, NJ).",[15],[31,34,36],{"name":32,"affiliation":5,"role":33},"Vinay Parikh, PhD","PRINCIPAL_INVESTIGATOR",{"name":35,"affiliation":5,"role":33},"Jason Chein, PhD",{"name":37,"affiliation":5,"role":33},"Tania Giovannetti, PhD",[39],{"name":32,"role":40,"phone":41,"phoneExt":25,"email":42},"CONTACT","215-204-1572","vinay.parikh@temple.edu",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":25},"RECRUITING","Philadelphia","Pennsylvania","19122","United States",{"type":51,"coordinates":52},"Point",[53,54],-75.16362,39.95238,{"lat":54,"lon":53},{"type":57,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100577885",false,"NCT06804109","Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study","Vaping and Vagal Neuromodulation of Cognition","nVNS","Inclusion Criteria:\n\n* Healthy young adults\n* Age range 18-25 years\n* Current or prior users of e-cigarettes\n\nExclusion Criteria:\n\nParticipants will be excluded from the study if they:\n\n* Have any rash, infection, swelling, cut, soreness, drug patch, surgical scar on the neck area\n* Have any implantable medical device in their body such as a pacemaker, hearing aid implant, or any other metallic\u002Felectronic device\n* Have any hearing or vision problems that are not corrected\n* Are pregnant or breastfeeding\n* Have any learning disabilities\n* Have a medical history of any of the following condition\n* Meningitis\n* Traumatic brain injury\n* Seizure\n* Syncope\n* Schizophrenia\n* Schizoaffective disorder\n* Bulimia (eating disorder)\n* Other serious neurological illness\n* Have a medical history of any of the following cardiac disorder\n\n  * Carotid atherosclerosis or carotid artery disease\n  * Cervical vagotomy\n  * First degree atrioventricular block or prolonged QT interval\n* Are taking any medications for to treat hypertension, arrhythmias, or are on calcium channel blockers",true,"ALL","18 Years","25 Years",{"count":70,"type":71},100,"ESTIMATED","INTERVENTIONAL",[74],"NA","The purpose of this study is to assess the effects of non-invasive vagus nerve stimulation (nNVS) on cognitive functioning in the users of e-cigarettes or vaping products. The investigators will use a digital wellness companion product (TRUVAGA™ device) that provides mild transcutaneous nVNS. The participants will be randomized to receive either a 2-min nNVS stimulation or control stimulation in the neck region followed by completion of three cognitive tests of attention and executive function.",[77],"Vaping",[79,80,81],"vaping","attention","non-invasive vagus nerve stimulation","2026-03-05",{"date":84,"type":85},"2026-03-06","ACTUAL",{"date":87,"type":85},"2025-03-18",{"date":89,"type":71},"2028-02-09",{"name":5,"class":6},1]